David Kroll
Concepts (447)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Topoisomerases, Type II | 11 | 2005 | 47 | 1.290 |
Why?
| | Antineoplastic Agents, Phytogenic | 16 | 2012 | 177 | 1.070 |
Why?
| | Plant Extracts | 10 | 2010 | 187 | 0.780 |
Why?
| | Silymarin | 10 | 2016 | 147 | 0.710 |
Why?
| | Phytotherapy | 8 | 2010 | 74 | 0.640 |
Why?
| | Isoenzymes | 5 | 2001 | 299 | 0.580 |
Why?
| | Plants, Medicinal | 7 | 2009 | 23 | 0.500 |
Why?
| | Antineoplastic Agents | 13 | 2016 | 2194 | 0.490 |
Why?
| | Prostatic Neoplasms | 10 | 2016 | 974 | 0.480 |
Why?
| | Topoisomerase II Inhibitors | 3 | 2005 | 26 | 0.400 |
Why?
| | Flavonolignans | 4 | 2009 | 9 | 0.390 |
Why?
| | Enzyme Inhibitors | 4 | 2012 | 824 | 0.390 |
Why?
| | Camptothecin | 4 | 2009 | 140 | 0.380 |
Why?
| | Hypocreales | 4 | 2013 | 8 | 0.380 |
Why?
| | Drug Interactions | 5 | 2010 | 398 | 0.370 |
Why?
| | Etoposide | 3 | 2001 | 166 | 0.360 |
Why?
| | Hypericum | 2 | 2001 | 3 | 0.360 |
Why?
| | Drug Screening Assays, Antitumor | 16 | 2013 | 191 | 0.350 |
Why?
| | Tumor Cells, Cultured | 9 | 2006 | 919 | 0.340 |
Why?
| | Transcriptional Activation | 4 | 1997 | 383 | 0.320 |
Why?
| | DNA | 9 | 2001 | 1463 | 0.280 |
Why?
| | Molecular Structure | 15 | 2013 | 499 | 0.270 |
Why?
| | Paclitaxel | 2 | 2009 | 255 | 0.250 |
Why?
| | Biological Products | 3 | 2012 | 252 | 0.240 |
Why?
| | Anti-Bacterial Agents | 6 | 2013 | 1907 | 0.240 |
Why?
| | Promoter Regions, Genetic | 4 | 2005 | 1257 | 0.230 |
Why?
| | Cell Line, Tumor | 19 | 2016 | 3540 | 0.230 |
Why?
| | Antigens, Neoplasm | 6 | 2005 | 271 | 0.220 |
Why?
| | Terminology as Topic | 1 | 2007 | 255 | 0.220 |
Why?
| | Plant Proteins | 2 | 2004 | 112 | 0.210 |
Why?
| | DNA-Binding Proteins | 6 | 2005 | 1499 | 0.210 |
Why?
| | Colchicum | 3 | 2010 | 3 | 0.200 |
Why?
| | Peptaibols | 2 | 2013 | 2 | 0.190 |
Why?
| | Butyrates | 2 | 2001 | 67 | 0.190 |
Why?
| | Terphenyl Compounds | 2 | 2013 | 4 | 0.190 |
Why?
| | Indole Alkaloids | 2 | 2012 | 7 | 0.190 |
Why?
| | Sesquiterpenes | 2 | 2013 | 52 | 0.180 |
Why?
| | Transfection | 5 | 2000 | 940 | 0.180 |
Why?
| | Herbal Medicine | 1 | 2001 | 4 | 0.180 |
Why?
| | Antifungal Agents | 2 | 2013 | 149 | 0.180 |
Why?
| | Perylene | 1 | 2001 | 10 | 0.180 |
Why?
| | Terpenes | 1 | 2001 | 25 | 0.180 |
Why?
| | Mixed Function Oxygenases | 1 | 2001 | 49 | 0.170 |
Why?
| | Benzene | 1 | 2001 | 18 | 0.170 |
Why?
| | Thylakoids | 1 | 2001 | 6 | 0.170 |
Why?
| | Drug Carriers | 3 | 1998 | 130 | 0.170 |
Why?
| | Aryl Hydrocarbon Hydroxylases | 2 | 2012 | 45 | 0.170 |
Why?
| | Genes, Plant | 1 | 2001 | 46 | 0.170 |
Why?
| | Hemostasis | 1 | 2001 | 102 | 0.170 |
Why?
| | Gene Expression Regulation, Enzymologic | 3 | 2008 | 269 | 0.170 |
Why?
| | Antioxidants | 4 | 2016 | 549 | 0.160 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2001 | 162 | 0.160 |
Why?
| | Biomedical Research | 1 | 2007 | 710 | 0.160 |
Why?
| | Dose-Response Relationship, Drug | 7 | 2012 | 2027 | 0.160 |
Why?
| | NF-kappa B | 4 | 2012 | 661 | 0.160 |
Why?
| | Arabidopsis Proteins | 1 | 2001 | 76 | 0.160 |
Why?
| | Dietary Supplements | 1 | 2004 | 576 | 0.160 |
Why?
| | Arabidopsis | 1 | 2001 | 95 | 0.160 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2001 | 220 | 0.160 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2016 | 436 | 0.150 |
Why?
| | Liposomes | 2 | 1998 | 250 | 0.150 |
Why?
| | Diterpenes | 3 | 2009 | 26 | 0.150 |
Why?
| | Ericales | 1 | 1999 | 2 | 0.150 |
Why?
| | Theophylline | 1 | 1999 | 41 | 0.150 |
Why?
| | Neoplasms | 4 | 2009 | 2875 | 0.150 |
Why?
| | Cell Cycle Proteins | 3 | 2008 | 628 | 0.140 |
Why?
| | Magnoliopsida | 1 | 1998 | 34 | 0.140 |
Why?
| | Annonaceae | 2 | 2009 | 3 | 0.140 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 8 | 2013 | 346 | 0.140 |
Why?
| | Receptors, Androgen | 2 | 2010 | 153 | 0.140 |
Why?
| | Humans | 55 | 2016 | 144759 | 0.140 |
Why?
| | Bronchodilator Agents | 1 | 1999 | 182 | 0.140 |
Why?
| | beta-Galactosidase | 1 | 1997 | 77 | 0.130 |
Why?
| | Cloning, Molecular | 2 | 2001 | 540 | 0.130 |
Why?
| | Nuclear Proteins | 3 | 2007 | 748 | 0.120 |
Why?
| | Enhancer of Zeste Homolog 2 Protein | 1 | 2016 | 56 | 0.120 |
Why?
| | Practice Guidelines as Topic | 1 | 2004 | 1560 | 0.120 |
Why?
| | Colchicine | 2 | 2006 | 21 | 0.120 |
Why?
| | Transcription Factors | 5 | 2016 | 1741 | 0.120 |
Why?
| | Polycomb Repressive Complex 2 | 1 | 2016 | 81 | 0.120 |
Why?
| | Fungi | 3 | 2011 | 161 | 0.110 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 2 | 1993 | 145 | 0.110 |
Why?
| | Leukemia, Promyelocytic, Acute | 1 | 1995 | 8 | 0.110 |
Why?
| | Plasmids | 2 | 1993 | 379 | 0.110 |
Why?
| | HL-60 Cells | 3 | 2001 | 29 | 0.110 |
Why?
| | HeLa Cells | 5 | 1997 | 650 | 0.110 |
Why?
| | COS Cells | 4 | 2000 | 181 | 0.110 |
Why?
| | Anthracenes | 2 | 2007 | 31 | 0.110 |
Why?
| | Cell Cycle | 3 | 2007 | 596 | 0.110 |
Why?
| | Gene Expression | 2 | 2005 | 1490 | 0.110 |
Why?
| | Membrane Proteins | 1 | 2001 | 1166 | 0.110 |
Why?
| | Trans-Activators | 1 | 1997 | 405 | 0.110 |
Why?
| | Microbial Sensitivity Tests | 6 | 2013 | 370 | 0.110 |
Why?
| | Antiviral Agents | 2 | 2012 | 767 | 0.100 |
Why?
| | Trichothecenes | 2 | 2011 | 4 | 0.100 |
Why?
| | Molecular Sequence Data | 7 | 2001 | 2930 | 0.100 |
Why?
| | Isocoumarins | 1 | 2013 | 1 | 0.100 |
Why?
| | Proto-Oncogene Proteins | 1 | 1997 | 623 | 0.100 |
Why?
| | Recombinant Fusion Proteins | 2 | 1993 | 675 | 0.100 |
Why?
| | Pyrrolidinones | 1 | 2013 | 29 | 0.100 |
Why?
| | Lipids | 1 | 1998 | 710 | 0.100 |
Why?
| | Apoptosis | 4 | 2010 | 2430 | 0.100 |
Why?
| | Aldehydes | 3 | 1999 | 142 | 0.100 |
Why?
| | Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2013 | 15 | 0.100 |
Why?
| | Phosphodiesterase 4 Inhibitors | 1 | 2013 | 12 | 0.100 |
Why?
| | Ascomycota | 1 | 2013 | 28 | 0.090 |
Why?
| | Drug Stability | 3 | 2009 | 164 | 0.090 |
Why?
| | Structure-Activity Relationship | 5 | 2012 | 570 | 0.090 |
Why?
| | Benzoquinones | 1 | 2013 | 47 | 0.090 |
Why?
| | Herb-Drug Interactions | 2 | 2009 | 4 | 0.090 |
Why?
| | Anthelmintics | 1 | 2012 | 12 | 0.090 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2016 | 1455 | 0.090 |
Why?
| | Disulfides | 1 | 2012 | 96 | 0.090 |
Why?
| | Monocytes | 1 | 1995 | 538 | 0.090 |
Why?
| | Anthraquinones | 1 | 2011 | 10 | 0.090 |
Why?
| | Xanthones | 1 | 2011 | 6 | 0.090 |
Why?
| | Drug Antagonism | 2 | 2001 | 9 | 0.090 |
Why?
| | Depsipeptides | 1 | 2011 | 15 | 0.090 |
Why?
| | Cyanobacteria | 1 | 2012 | 55 | 0.090 |
Why?
| | Zearalenone | 1 | 2011 | 2 | 0.090 |
Why?
| | Cyclin-Dependent Kinases | 3 | 2008 | 123 | 0.090 |
Why?
| | Hepacivirus | 1 | 2012 | 243 | 0.080 |
Why?
| | Lactones | 1 | 2011 | 58 | 0.080 |
Why?
| | Drug Discovery | 1 | 2012 | 155 | 0.080 |
Why?
| | Macrocyclic Compounds | 1 | 2010 | 13 | 0.080 |
Why?
| | Drug Evaluation, Preclinical | 2 | 2010 | 194 | 0.080 |
Why?
| | Melanoma, Experimental | 1 | 1990 | 108 | 0.080 |
Why?
| | Piperazines | 1 | 2012 | 381 | 0.080 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 3 | 1997 | 331 | 0.080 |
Why?
| | Base Sequence | 6 | 1999 | 2190 | 0.080 |
Why?
| | Leukemia | 2 | 2001 | 245 | 0.070 |
Why?
| | Ginkgo biloba | 1 | 2009 | 10 | 0.070 |
Why?
| | Amino Acid Sequence | 4 | 2001 | 2155 | 0.070 |
Why?
| | Recombinant Proteins | 4 | 2009 | 1370 | 0.070 |
Why?
| | Acclimatization | 1 | 1990 | 172 | 0.070 |
Why?
| | Echium | 1 | 2008 | 1 | 0.070 |
Why?
| | Plant Preparations | 1 | 2009 | 37 | 0.070 |
Why?
| | Pyrrolizidine Alkaloids | 1 | 2008 | 11 | 0.070 |
Why?
| | Animals | 20 | 2012 | 38058 | 0.070 |
Why?
| | Glutathione Transferase | 2 | 1999 | 100 | 0.070 |
Why?
| | Warfarin | 1 | 2009 | 170 | 0.070 |
Why?
| | Staphylococcus aureus | 1 | 2013 | 455 | 0.070 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2010 | 139 | 0.070 |
Why?
| | Prostate-Specific Antigen | 2 | 2008 | 161 | 0.070 |
Why?
| | Mercuric Chloride | 1 | 1988 | 2 | 0.070 |
Why?
| | Microsomes | 1 | 1988 | 33 | 0.070 |
Why?
| | Epoxide Hydrolases | 1 | 1988 | 13 | 0.070 |
Why?
| | ErbB Receptors | 2 | 2012 | 627 | 0.070 |
Why?
| | Protective Agents | 1 | 2008 | 42 | 0.070 |
Why?
| | Quaternary Ammonium Compounds | 2 | 1998 | 52 | 0.070 |
Why?
| | Fatty Acids, Monounsaturated | 2 | 1998 | 54 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 1 | 2008 | 66 | 0.070 |
Why?
| | Simaroubaceae | 1 | 2007 | 1 | 0.070 |
Why?
| | Immunoconjugates | 1 | 2009 | 132 | 0.070 |
Why?
| | Hepatocytes | 1 | 2009 | 223 | 0.070 |
Why?
| | Phosphorylation | 5 | 2016 | 1732 | 0.070 |
Why?
| | Hot Temperature | 1 | 1990 | 407 | 0.070 |
Why?
| | Pharmacokinetics | 1 | 2007 | 32 | 0.070 |
Why?
| | Monosaccharides | 1 | 2007 | 13 | 0.070 |
Why?
| | Herpesvirus 8, Human | 1 | 2007 | 68 | 0.060 |
Why?
| | Anti-Infective Agents | 1 | 2009 | 242 | 0.060 |
Why?
| | Dendrimers | 1 | 2006 | 20 | 0.060 |
Why?
| | Blotting, Western | 5 | 2008 | 1187 | 0.060 |
Why?
| | DNA, Neoplasm | 2 | 2001 | 163 | 0.060 |
Why?
| | Anticarcinogenic Agents | 1 | 2007 | 61 | 0.060 |
Why?
| | Genes | 1 | 1987 | 226 | 0.060 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2010 | 293 | 0.060 |
Why?
| | Magnetic Resonance Spectroscopy | 4 | 2012 | 630 | 0.060 |
Why?
| | Flavones | 1 | 2006 | 11 | 0.060 |
Why?
| | Calendula | 1 | 2006 | 1 | 0.060 |
Why?
| | Case Management | 1 | 2006 | 67 | 0.060 |
Why?
| | Heat-Shock Proteins | 1 | 1987 | 138 | 0.060 |
Why?
| | Microsomes, Liver | 3 | 2012 | 85 | 0.060 |
Why?
| | Candida albicans | 3 | 2013 | 61 | 0.060 |
Why?
| | Patient Dropouts | 1 | 2006 | 65 | 0.060 |
Why?
| | Purines | 1 | 2007 | 187 | 0.060 |
Why?
| | Antibodies, Monoclonal | 2 | 2009 | 1519 | 0.060 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2008 | 380 | 0.060 |
Why?
| | Chromatography, Affinity | 2 | 1997 | 85 | 0.060 |
Why?
| | Models, Biological | 3 | 2008 | 1821 | 0.060 |
Why?
| | Cell Growth Processes | 1 | 2005 | 50 | 0.060 |
Why?
| | Genetic Variation | 1 | 1990 | 983 | 0.060 |
Why?
| | Asteraceae | 1 | 2005 | 20 | 0.060 |
Why?
| | In Vitro Techniques | 3 | 2009 | 1047 | 0.060 |
Why?
| | Neoplasms, Hormone-Dependent | 1 | 2005 | 41 | 0.060 |
Why?
| | Alkaloids | 1 | 2005 | 28 | 0.060 |
Why?
| | Protein Binding | 3 | 2001 | 2273 | 0.050 |
Why?
| | Hypersensitivity, Delayed | 1 | 2004 | 29 | 0.050 |
Why?
| | Transcription, Genetic | 2 | 1993 | 1496 | 0.050 |
Why?
| | Societies, Pharmaceutical | 1 | 2004 | 14 | 0.050 |
Why?
| | Diospyros | 1 | 2004 | 1 | 0.050 |
Why?
| | Naphthoquinones | 1 | 2004 | 19 | 0.050 |
Why?
| | Anticoagulants | 1 | 2009 | 722 | 0.050 |
Why?
| | Liver | 2 | 2007 | 1887 | 0.050 |
Why?
| | Methylation | 2 | 2016 | 242 | 0.050 |
Why?
| | Clinical Trials as Topic | 2 | 2006 | 1053 | 0.050 |
Why?
| | Taxus | 1 | 2004 | 1 | 0.050 |
Why?
| | Camptotheca | 1 | 2004 | 1 | 0.050 |
Why?
| | Topoisomerase I Inhibitors | 1 | 2004 | 19 | 0.050 |
Why?
| | Carcinoma | 1 | 2006 | 228 | 0.050 |
Why?
| | Pharmaceutical Services | 1 | 2004 | 78 | 0.050 |
Why?
| | Cell Survival | 4 | 2012 | 1098 | 0.050 |
Why?
| | Leucine Zippers | 2 | 1993 | 17 | 0.050 |
Why?
| | Deoxycytidine | 1 | 2004 | 221 | 0.050 |
Why?
| | Stereoisomerism | 3 | 2009 | 104 | 0.050 |
Why?
| | Proteins | 2 | 2000 | 1021 | 0.050 |
Why?
| | History, 20th Century | 1 | 2004 | 325 | 0.050 |
Why?
| | Patient Selection | 1 | 2006 | 719 | 0.050 |
Why?
| | Cell Proliferation | 4 | 2012 | 2496 | 0.050 |
Why?
| | Patient Compliance | 1 | 2006 | 588 | 0.040 |
Why?
| | Phloroglucinol | 1 | 2001 | 1 | 0.040 |
Why?
| | Membrane Potential, Mitochondrial | 2 | 2012 | 75 | 0.040 |
Why?
| | Bridged Bicyclo Compounds | 1 | 2001 | 14 | 0.040 |
Why?
| | DNA Fragmentation | 1 | 2001 | 39 | 0.040 |
Why?
| | Evidence-Based Medicine | 1 | 2006 | 732 | 0.040 |
Why?
| | Cytochrome P-450 CYP2C9 | 2 | 2012 | 19 | 0.040 |
Why?
| | Plastids | 1 | 2001 | 2 | 0.040 |
Why?
| | Eubacterium | 1 | 2001 | 3 | 0.040 |
Why?
| | Peptide Fragments | 2 | 1997 | 699 | 0.040 |
Why?
| | Spectrophotometry, Ultraviolet | 2 | 2011 | 85 | 0.040 |
Why?
| | Male | 14 | 2016 | 72315 | 0.040 |
Why?
| | Cytochrome P-450 CYP3A | 1 | 2001 | 93 | 0.040 |
Why?
| | DNA, Single-Stranded | 2 | 1993 | 119 | 0.040 |
Why?
| | Carcinogens | 1 | 2001 | 122 | 0.040 |
Why?
| | Cell Nucleus | 3 | 2010 | 618 | 0.040 |
Why?
| | Family Practice | 1 | 2004 | 404 | 0.040 |
Why?
| | Catalysis | 1 | 2001 | 322 | 0.040 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2001 | 396 | 0.040 |
Why?
| | Pharmacogenetics | 1 | 2001 | 172 | 0.040 |
Why?
| | Tyrosine 3-Monooxygenase | 1 | 2000 | 71 | 0.040 |
Why?
| | Photosynthesis | 1 | 2001 | 98 | 0.040 |
Why?
| | Escherichia coli | 3 | 1993 | 854 | 0.040 |
Why?
| | Detergents | 1 | 2000 | 44 | 0.040 |
Why?
| | Kidney | 1 | 1988 | 1495 | 0.040 |
Why?
| | Glycosides | 2 | 2013 | 42 | 0.040 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 2 | 2013 | 248 | 0.040 |
Why?
| | Neoplasm Proteins | 2 | 2016 | 442 | 0.040 |
Why?
| | Biocompatible Materials | 2 | 2006 | 435 | 0.040 |
Why?
| | Esters | 1 | 2000 | 78 | 0.040 |
Why?
| | Serine Endopeptidases | 1 | 2000 | 128 | 0.040 |
Why?
| | Patient Education as Topic | 1 | 2004 | 780 | 0.040 |
Why?
| | Proteasome Endopeptidase Complex | 2 | 2011 | 159 | 0.040 |
Why?
| | Cation Exchange Resins | 1 | 1998 | 7 | 0.040 |
Why?
| | DNA Damage | 1 | 2001 | 430 | 0.040 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 2 | 2011 | 179 | 0.040 |
Why?
| | Response Elements | 1 | 1999 | 89 | 0.040 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 1998 | 96 | 0.030 |
Why?
| | Arginine | 1 | 2000 | 262 | 0.030 |
Why?
| | Gentamicins | 1 | 1998 | 51 | 0.030 |
Why?
| | Freezing | 1 | 1998 | 86 | 0.030 |
Why?
| | Thymidine | 2 | 1995 | 60 | 0.030 |
Why?
| | Carcinoma, Hepatocellular | 2 | 1999 | 370 | 0.030 |
Why?
| | DNA Replication | 2 | 1997 | 251 | 0.030 |
Why?
| | Cyclin-Dependent Kinase Inhibitor Proteins | 2 | 2008 | 7 | 0.030 |
Why?
| | Cell Division | 2 | 1997 | 766 | 0.030 |
Why?
| | Polyesters | 1 | 1998 | 80 | 0.030 |
Why?
| | Saccharomyces cerevisiae | 3 | 2009 | 579 | 0.030 |
Why?
| | Trehalose | 1 | 1997 | 35 | 0.030 |
Why?
| | Malondialdehyde | 1 | 1997 | 30 | 0.030 |
Why?
| | Scattering, Radiation | 1 | 1997 | 103 | 0.030 |
Why?
| | Mass Screening | 1 | 2006 | 1347 | 0.030 |
Why?
| | Plant Bark | 2 | 2009 | 11 | 0.030 |
Why?
| | Enzyme Stability | 1 | 1997 | 73 | 0.030 |
Why?
| | Aspergillus niger | 2 | 2009 | 10 | 0.030 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 1 | 1997 | 38 | 0.030 |
Why?
| | Phosphatidylethanolamines | 1 | 1997 | 76 | 0.030 |
Why?
| | Indonesia | 2 | 2009 | 23 | 0.030 |
Why?
| | Freeze Drying | 1 | 1997 | 82 | 0.030 |
Why?
| | Drug Costs | 1 | 1998 | 116 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-myb | 1 | 1997 | 10 | 0.030 |
Why?
| | Sucrose | 1 | 1997 | 112 | 0.030 |
Why?
| | Dimerization | 1 | 1997 | 194 | 0.030 |
Why?
| | Histone Deacetylase 2 | 1 | 2016 | 10 | 0.030 |
Why?
| | Histone Deacetylase 1 | 1 | 2016 | 23 | 0.030 |
Why?
| | Lipid Peroxidation | 1 | 1997 | 160 | 0.030 |
Why?
| | Signal Transduction | 1 | 2010 | 5226 | 0.030 |
Why?
| | Protein Conformation | 2 | 1997 | 946 | 0.030 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 1 | 2016 | 37 | 0.030 |
Why?
| | Enzyme Activation | 3 | 2007 | 766 | 0.030 |
Why?
| | Sequence Deletion | 1 | 1997 | 193 | 0.030 |
Why?
| | Binding Sites | 2 | 1997 | 1329 | 0.030 |
Why?
| | Cytoplasm | 2 | 2008 | 269 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-jun | 2 | 1993 | 55 | 0.030 |
Why?
| | KB Cells | 2 | 2007 | 4 | 0.030 |
Why?
| | Precipitin Tests | 2 | 1997 | 93 | 0.030 |
Why?
| | Jordan | 2 | 2006 | 5 | 0.030 |
Why?
| | Artemia | 2 | 2006 | 8 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2016 | 341 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-fos | 2 | 1993 | 196 | 0.030 |
Why?
| | Butyric Acid | 1 | 1995 | 6 | 0.030 |
Why?
| | Breast Neoplasms | 2 | 2006 | 2452 | 0.030 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 1995 | 153 | 0.030 |
Why?
| | Drug Delivery Systems | 1 | 1998 | 380 | 0.030 |
Why?
| | Time Factors | 3 | 2008 | 7173 | 0.030 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2004 | 1953 | 0.030 |
Why?
| | Light | 1 | 1997 | 411 | 0.030 |
Why?
| | Genes, Reporter | 1 | 1995 | 275 | 0.030 |
Why?
| | Kinetics | 1 | 1997 | 1627 | 0.030 |
Why?
| | United States | 2 | 2004 | 15966 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 1997 | 1087 | 0.020 |
Why?
| | Bacteriophage T7 | 1 | 1993 | 5 | 0.020 |
Why?
| | Protein Sorting Signals | 1 | 1993 | 20 | 0.020 |
Why?
| | DNA, Recombinant | 1 | 1993 | 48 | 0.020 |
Why?
| | Adenovirus E1A Proteins | 1 | 1993 | 12 | 0.020 |
Why?
| | Kidney Tubules | 1 | 1994 | 117 | 0.020 |
Why?
| | DNA, Superhelical | 1 | 1993 | 12 | 0.020 |
Why?
| | Glioblastoma | 2 | 2007 | 353 | 0.020 |
Why?
| | Female | 8 | 2013 | 78271 | 0.020 |
Why?
| | Nickel | 1 | 1993 | 64 | 0.020 |
Why?
| | Haemonchus | 1 | 2012 | 1 | 0.020 |
Why?
| | Rats | 4 | 1999 | 5597 | 0.020 |
Why?
| | Phenotype | 1 | 2001 | 3162 | 0.020 |
Why?
| | Mice | 4 | 2012 | 18339 | 0.020 |
Why?
| | Glucose | 1 | 1997 | 1047 | 0.020 |
Why?
| | Mutagenesis, Site-Directed | 1 | 1993 | 381 | 0.020 |
Why?
| | Optical Rotation | 1 | 2011 | 1 | 0.020 |
Why?
| | Spectrophotometry, Infrared | 1 | 2011 | 55 | 0.020 |
Why?
| | Epigenesis, Genetic | 1 | 2016 | 684 | 0.020 |
Why?
| | Depression | 1 | 2001 | 1558 | 0.020 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2012 | 139 | 0.020 |
Why?
| | Resorcinols | 1 | 2011 | 5 | 0.020 |
Why?
| | Hydroxybenzoates | 1 | 2011 | 11 | 0.020 |
Why?
| | Crystallography, X-Ray | 1 | 2013 | 492 | 0.020 |
Why?
| | Transforming Growth Factor beta | 1 | 1994 | 479 | 0.020 |
Why?
| | Histones | 1 | 2016 | 669 | 0.020 |
Why?
| | Blood Proteins | 1 | 1993 | 249 | 0.020 |
Why?
| | Epitopes | 1 | 1993 | 485 | 0.020 |
Why?
| | Daunorubicin | 1 | 1990 | 25 | 0.020 |
Why?
| | Gene Expression Regulation | 2 | 1993 | 2608 | 0.020 |
Why?
| | Caspase 8 | 1 | 2010 | 47 | 0.020 |
Why?
| | Protein Kinases | 1 | 1992 | 315 | 0.020 |
Why?
| | Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2010 | 31 | 0.020 |
Why?
| | RNA, Messenger | 1 | 1998 | 2832 | 0.020 |
Why?
| | Drug Tolerance | 1 | 1990 | 100 | 0.020 |
Why?
| | Transcription Factor RelA | 1 | 2010 | 85 | 0.020 |
Why?
| | Phosphates | 1 | 1991 | 180 | 0.020 |
Why?
| | Aporphines | 1 | 2009 | 1 | 0.020 |
Why?
| | Micrococcus luteus | 1 | 2009 | 3 | 0.020 |
Why?
| | Hydroxylation | 1 | 2009 | 49 | 0.020 |
Why?
| | Liver Function Tests | 1 | 2010 | 106 | 0.020 |
Why?
| | Placebos | 1 | 2010 | 192 | 0.020 |
Why?
| | Spectrum Analysis | 1 | 2010 | 93 | 0.020 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2011 | 594 | 0.020 |
Why?
| | Inhibitory Concentration 50 | 1 | 2009 | 91 | 0.020 |
Why?
| | Cell Culture Techniques | 1 | 2012 | 375 | 0.020 |
Why?
| | Antibody Specificity | 1 | 2009 | 181 | 0.020 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 2008 | 49 | 0.020 |
Why?
| | Acrolein | 2 | 1999 | 22 | 0.020 |
Why?
| | Cell Line | 2 | 1994 | 2882 | 0.020 |
Why?
| | Mycobacterium tuberculosis | 1 | 2012 | 334 | 0.020 |
Why?
| | cdc25 Phosphatases | 1 | 2008 | 13 | 0.020 |
Why?
| | Isomerism | 1 | 2008 | 57 | 0.020 |
Why?
| | Indoles | 1 | 2012 | 501 | 0.020 |
Why?
| | Transplantation, Heterologous | 1 | 2008 | 193 | 0.020 |
Why?
| | Microcirculation | 1 | 2008 | 138 | 0.020 |
Why?
| | Drug Design | 1 | 2009 | 173 | 0.020 |
Why?
| | Mycobacterium | 1 | 2009 | 116 | 0.020 |
Why?
| | Bacteria | 2 | 2005 | 889 | 0.020 |
Why?
| | Metallothionein | 1 | 1988 | 25 | 0.020 |
Why?
| | Doxorubicin | 1 | 1990 | 397 | 0.020 |
Why?
| | Molecular Conformation | 1 | 2008 | 148 | 0.020 |
Why?
| | Cyclins | 1 | 2008 | 84 | 0.020 |
Why?
| | Enzyme Induction | 1 | 1988 | 88 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 1988 | 321 | 0.020 |
Why?
| | Leukemia P388 | 1 | 2007 | 7 | 0.020 |
Why?
| | Rats, Inbred F344 | 1 | 1988 | 268 | 0.020 |
Why?
| | Cells, Cultured | 3 | 1994 | 4154 | 0.020 |
Why?
| | Dominican Republic | 1 | 2007 | 26 | 0.020 |
Why?
| | Peptides | 1 | 2013 | 995 | 0.020 |
Why?
| | DNA Topoisomerases, Type I | 1 | 1987 | 16 | 0.020 |
Why?
| | Inhibitor of Apoptosis Proteins | 1 | 2007 | 47 | 0.020 |
Why?
| | Cell Differentiation | 1 | 1995 | 2050 | 0.020 |
Why?
| | Amino Acids | 1 | 1991 | 521 | 0.020 |
Why?
| | Mice, Nude | 1 | 2008 | 682 | 0.020 |
Why?
| | Angiogenesis Inhibitors | 1 | 2008 | 237 | 0.020 |
Why?
| | Fluorescence | 1 | 2007 | 161 | 0.020 |
Why?
| | Capsules | 1 | 2006 | 43 | 0.020 |
Why?
| | Biological Assay | 1 | 2007 | 128 | 0.020 |
Why?
| | Antigens, Viral | 1 | 2007 | 182 | 0.020 |
Why?
| | Species Specificity | 1 | 1988 | 574 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2007 | 370 | 0.020 |
Why?
| | Blotting, Northern | 2 | 1998 | 204 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2009 | 1253 | 0.020 |
Why?
| | Solubility | 1 | 2006 | 242 | 0.020 |
Why?
| | Caspases | 1 | 2007 | 232 | 0.010 |
Why?
| | Plant Leaves | 1 | 2007 | 137 | 0.010 |
Why?
| | Glutathione | 1 | 1988 | 375 | 0.010 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2008 | 557 | 0.010 |
Why?
| | Amphotericin B | 1 | 2005 | 37 | 0.010 |
Why?
| | Microtubule-Associated Proteins | 1 | 2007 | 196 | 0.010 |
Why?
| | Plant Components, Aerial | 1 | 2005 | 3 | 0.010 |
Why?
| | Cell Death | 1 | 2007 | 383 | 0.010 |
Why?
| | Biological Transport | 1 | 2006 | 417 | 0.010 |
Why?
| | Culture | 1 | 2006 | 125 | 0.010 |
Why?
| | Social Work | 1 | 2006 | 85 | 0.010 |
Why?
| | Telephone | 1 | 2006 | 175 | 0.010 |
Why?
| | Drosophila | 1 | 1987 | 166 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 983 | 0.010 |
Why?
| | Double-Blind Method | 1 | 2010 | 2029 | 0.010 |
Why?
| | Coumarins | 1 | 2004 | 17 | 0.010 |
Why?
| | Cognition Disorders | 1 | 2009 | 538 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2008 | 1173 | 0.010 |
Why?
| | Pilot Projects | 1 | 2010 | 1886 | 0.010 |
Why?
| | Fluorouracil | 1 | 2004 | 235 | 0.010 |
Why?
| | Methotrexate | 1 | 2004 | 240 | 0.010 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2004 | 421 | 0.010 |
Why?
| | Models, Molecular | 1 | 2008 | 1618 | 0.010 |
Why?
| | Poverty | 1 | 2006 | 529 | 0.010 |
Why?
| | Social Support | 1 | 2006 | 652 | 0.010 |
Why?
| | 14-3-3 Proteins | 1 | 2000 | 15 | 0.010 |
Why?
| | Cations | 1 | 2000 | 82 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2007 | 3409 | 0.010 |
Why?
| | Ethacrynic Acid | 1 | 1998 | 1 | 0.010 |
Why?
| | Absorption | 1 | 1998 | 60 | 0.010 |
Why?
| | Colorectal Neoplasms | 1 | 2006 | 845 | 0.010 |
Why?
| | Chemistry, Pharmaceutical | 1 | 1998 | 109 | 0.010 |
Why?
| | Cross-Linking Reagents | 1 | 1998 | 207 | 0.010 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2006 | 1180 | 0.010 |
Why?
| | Immune Sera | 1 | 1997 | 77 | 0.010 |
Why?
| | Brain Neoplasms | 1 | 2006 | 1318 | 0.010 |
Why?
| | Oxidants | 1 | 1997 | 103 | 0.010 |
Why?
| | Immunoblotting | 1 | 1997 | 300 | 0.010 |
Why?
| | Osteomyelitis | 1 | 1998 | 143 | 0.010 |
Why?
| | Rabbits | 1 | 1997 | 648 | 0.010 |
Why?
| | Adult | 1 | 1999 | 40449 | 0.010 |
Why?
| | Infant | 1 | 2010 | 10034 | 0.010 |
Why?
| | Child, Preschool | 1 | 2010 | 11787 | 0.010 |
Why?
| | Growth Substances | 1 | 1994 | 140 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2006 | 8265 | 0.010 |
Why?
| | Activating Transcription Factors | 1 | 1993 | 3 | 0.010 |
Why?
| | Lung Neoplasms | 1 | 2006 | 2637 | 0.010 |
Why?
| | Epithelium | 1 | 1994 | 314 | 0.010 |
Why?
| | Baculoviridae | 1 | 1992 | 44 | 0.010 |
Why?
| | Zinc Fingers | 1 | 1992 | 53 | 0.010 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1992 | 168 | 0.010 |
Why?
| | Moths | 1 | 1992 | 52 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 1997 | 2527 | 0.010 |
Why?
| | Swine | 1 | 1994 | 833 | 0.010 |
Why?
| | Genetic Vectors | 1 | 1992 | 337 | 0.010 |
Why?
| | Adolescent | 1 | 2010 | 22428 | 0.000 |
Why?
| | Zinc | 1 | 1993 | 295 | 0.000 |
Why?
| | Protein Processing, Post-Translational | 1 | 1992 | 477 | 0.000 |
Why?
| | Child | 1 | 2010 | 22633 | 0.000 |
Why?
| | Epithelial Cells | 1 | 1994 | 1125 | 0.000 |
Why?
| | Aged | 1 | 2006 | 25913 | 0.000 |
Why?
| | Middle Aged | 1 | 2006 | 35875 | 0.000 |
Why?
| | Mutation | 1 | 1993 | 4089 | 0.000 |
Why?
|
|
Kroll's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|